Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Investigational glucagon-like peptide-1 agonists for the treatment of obesity
HTML
Details
Locations
Year:
2016
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1080/13543784.2016.1221925
Authors:
Brian Tomlinson,
Miao Hu,
Yuzhen Zhang,
Paul Chan,
Zhong-Min Liu
Institutions:
Tongji University,
Chinese University of Hong Kong,
Shanghai East Hospital,
Wan Fang Hospital,
Taipei Medical University
Language:
English
Topic:
Pharmacology and Obesity Treatment
Subfield:
Pharmacology (medical)
Field:
Medicine
Domain:
Health Sciences
Keywords:
obesity,
GLP-1 receptor agonists,
liraglutide,
type 2 diabetes,
obesity pharmacotherapy,
weight loss,
pancreatitis risk,
neoplasms,
nausea,
gastrointestinal adverse effects,
subcutaneous injection,
patient adherence,
cardiovascular outcomes
show all 13
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2508533215
FWCI:
0.372
Cites:
105
Cited by:
27
Related to:
10